SCHEMBL8024

SCHEMBL8024

NC(=O)c1nc[nH]c1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25275928 0.98 GDA (0.50)
Hydrochloric Acid SCHEMBL1775253 0.98 GDA (0.50)
Phosphoric Acid SCHEMBL7627085 0.92 GDA (0.46)
SCHEMBL3258892 0.84 GDA (0.43)
SCHEMBL71570 0.82
SCHEMBL13176680 0.80
SCHEMBL19018643 0.80 GAA (0.51)
SCHEMBL1560676 0.79 GDA (0.41)
SCHEMBL3025277 0.77
SCHEMBL17984775 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2528 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4652841-A1 SUBSTANCE (HATCHING ACCELERATOR) ACCELERATING HATCHING OF CYST NEMATODES Hirotsu Bio Science Inc. (JP) 2025-11-26 EP claimed
WO-2025104700-A2 IMPROVED METHODS FOR CRYOPRESERVATION AND FITNESS OF NATURAL KILLER CELLS, AND COMPOSITIONS THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-05-22 WO claimed
EP-3911330-B1 DNA-PKCS INHIBITORS FOR INCREASING GENOME EDITING EFFICIENCY MAX PLANCK GESELLSCHAFT (DE) 2025-03-05 EP claimed
EP-4499056-A1 A SPHINGOSINE-1-PHOSPHATE RECEPTOR (S1PR) MODULATOR FOR USE IN TREATING A PATIENT SUFFERING FROM ALZHEIMER'S DEMENTIA Otto-von-Guericke-Universität Magdeburg (DE) 2025-02-05 EP claimed
US-20250027930-A1 SMALL MOLECULES FOR REPROGRAMING ANTI-TUMOR IMMUNITY OF T CELLS NATIONAL INSTITUTES OF HEALTH 2025-01-23 US claimed
CN-119326951-A Small-caliber tissue engineering vascular stent and preparation method thereof 新乡医学院 2025-01-21 CN claimed
CN-119285947-A Low-temperature curing polyimide precursor solution and preparation method thereof 北京化工大学常州先进材料研究院 2025-01-10 CN claimed
CN-119230972-A Mixed electrolyte containing amino, imidazolyl and sulfonic acid groups, and preparation method and application thereof 南方科技大学 2024-12-31 CN claimed
CN-118766906-A Stable antitumor pharmaceutical composition containing temozolomide and preparation method of composition 双键医药品股份公司 2024-10-15 CN claimed
CN-118456878-A Low-cost high-efficiency processing method based on 3D printing part 裕克施乐塑料制品(太仓)有限公司 2024-08-09 CN claimed
WO-1997003668-A1 TREATMENT AND PREVENTION OF NEOPLASMS WITH SALTS OF AMINOIMIDAZOLE CARBOXAMIDE AND 5-AMINO OR SUBSTITUTED AMINO 1,2,3-TRIAZOLES CONSTANTIA GRUPPE (AT) 1997-02-06 WO claimed
US-5459129-A Antitumor agents; enzyme inhibitors TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-10-17 US claimed
EP-0674529-A1 LIPID PRODRUGS FOR ORAL ADMINISTRATION NeXstar Pharmaceuticals, Inc. (US) 1995-10-04 EP claimed
US-5411947-A converting drugs having suitable functional groups to 1-O-alkyl-, 1-O-acyl-, 1-S-acyl, and 1-S-alkyl-sn-glycero-3-phosphate derivatives; drugs such as AZT, cladribine, AICA-Riboside VESTAR, INC. (US) 1995-05-02 US claimed
WO-1994013324-A1 LIPID PRODRUGS FOR ORAL ADMINISTRATION VESTAR, INC. (US) 1994-06-23 WO claimed
US-5268362-A Containing benzene and purine rings TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-12-07 US claimed
US-RE34387-E Method for restoring depleted purine nucleotide pools DUKE UNIVERSITY (US) 1993-09-21 US claimed
EP-0492316-A1 Condensed heterocyclic oligoglutamate derivatives, their production and pharmaceutical compositions containing them Takeda Chemical Industries, Ltd. (JP) 1992-07-01 EP claimed
US-5082829-A 5-amino-4-imidazolecarboxamide riboside to increase adenosine concentration, cardiovascular, seizures GENSIA PHARMACEUTICALS (US) 1992-01-21 US claimed
US-4028184-A CULTURING CORYNEBACTERIUM, ARTHROBACTER, MICROBACTERIUM KIKKOMAN SHOYU CO., LTD. (JA) 1977-06-07 US claimed